Capital Health acquires Calea (Canada)
On August 29, 2025, Capital Health Partners Inc. (“Capital Health”) entered into an agreement to acquire all the issued and outstanding shares of Calea Ltd. (and certain affiliates), a leading provider of home infusion and total parenteral nutrition (TPN) services, from Fresenius Kabi AG.
Further information can be found on Capital Health’s website.
Capital Health is a Canadian healthcare company committed on becoming a leading distributor of medical supplies, equipment, and pharmaceuticals and provider of pharmacy services across Canada. Its primary emphasis is on delivering industry-leading and cost-effective healthcare solutions that optimize patient support and quality of life.
Calea provides expert solutions and support resources to health care professionals, hospitals and patients and is a Canadian leader in the provision of products and services that safely and reliably support community-based infusion therapy, advanced wound care and the need for general medical supplies.